The N-Terminal Domain of EspF Induces Host Cell Apoptosis after Infection with Enterohaemorrhagic Escherichia coli O157:H7

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Zhao, Suhui ^a   Zhou, Ying ^a   Wang, Chunhui ^a   Yang, Yu ^a   Wu, Xianbo ^a   Wei, Yao ^a   Zhu, Li ^a   Zhao, Wei ^a   Zhang, Qiwei ^a   Wan, Chengsong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CASPASE 3; CASPASE 9; HEAT SHOCK PROTEIN 70; LACTATE DEHYDROGENASE; PROTEIN ESPF; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CONTROLLED STUDY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HOST CELL; HOST PATHOGEN INTERACTION; INTESTINE EPITHELIUM CELL; MICROBIAL ADHESION; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; SURVIVAL RATE;

ANIMALS; APOPTOSIS; BACTERIAL ADHESION; BACTERIAL SECRETION SYSTEMS; CARRIER PROTEINS; CELL LINE; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; ESCHERICHIA COLI PROTEINS; HOST-PATHOGEN INTERACTIONS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED BALB C; MITOCHONDRIA; MUTATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; VIRULENCE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84872856788     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055164     Document Type: Article

References (41)

1. Kaper JB, Nataro JP, Mobley HL, (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2: 123-140.
2. Rangel JM, Sparling PH, Crowe C, Griffin PM, Swerdlow DL, (2005) Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg Infect Dis 11: 603-609.
3. Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, et al. (1983) Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308: 681-685.
4. Lodato PB, Kaper JB, (2009) Post-transcriptional processing of the LEE4 operon in enterohaemorrhagic Escherichia coli. Mol Microbiol 71: 273-290.
5. Berdichevsky T, Friedberg D, Nadler C, Rokney A, Oppenheim A, et al. (2005) Ler is a negative autoregulator of the LEE1 operon in enteropathogenic Escherichia coli. J Bacteriol 187: 349-357.
6. Garmendia J, Frankel G, Crepin VF, (2005) Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect Immun 73: 2573-2585.
7. Nataro JP, Kaper JB, (1998) Diarrheagenic Escherichia coli. Clin Microbiol Rev 11: 142-201.
8. Dean P, Kenny B, (2009) The effector repertoire of enteropathogenic E. coli: ganging up on the host cell. Curr Opin Microbiol 12: 101-109.
9. Aitio O, Hellman M, Skehan B, Kesti T, Leong JM, et al. (2012) Enterohaemorrhagic Escherichia coli Exploits a Tryptophan Switch to Hijack Host F-Actin Assembly. Structure.
10. McNamara BP, Donnenberg MS, (1998) A novel proline-rich protein, EspF, is secreted from enteropathogenic Escherichia coli via the type III export pathway. FEMS Microbiol Lett 166: 71-78.
11. Viswanathan VK, Koutsouris A, Lukic S, Pilkinton M, Simonovic I, et al. (2004) Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function. Infect Immun 72: 3218-3227.
12. Alto NM, Weflen AW, Rardin MJ, Yarar D, Lazar CS, et al. (2007) The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways. J Cell Biol 178: 1265-1278.
13. Mayer BJ, (2001) SH3 domains: complexity in moderation. J Cell Sci 114: 1253-1263.
14. Dean P, Scott JA, Knox AA, Quitard S, Watkins NJ, et al. (2010) The enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process regulated by mitochondrial dysfunction. PLoS Pathog 6: e1000961.
15. Nagai T, Abe A, Sasakawa C, (2005) Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF. J Biol Chem 280: 2998-3011.
16. Nougayrede JP, Donnenberg MS, (2004) Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. Cell Microbiol 6: 1097-1111.
17. Marches O, Batchelor M, Shaw RK, Patel A, Cummings N, et al. (2006) EspF of enteropathogenic Escherichia coli binds sorting nexin 9. J Bacteriol 188: 3110-3115.
18. Weflen AW, Alto NM, Viswanathan VK, Hecht G, (2010) E. coli secreted protein F promotes EPEC invasion of intestinal epithelial cells via an SNX9-dependent mechanism. Cell Microbiol 12: 919-929.
19. Campellone KG, Siripala AD, Leong JM, Welch MD, (2012) Membrane-deforming proteins play distinct roles in actin pedestal biogenesis by enterohemorrhagic Escherichia coli. J Biol Chem 287: 20613-20624.
20. Viswanathan VK, Lukic S, Koutsouris A, Miao R, Muza MM, et al. (2004) Cytokeratin 18 interacts with the enteropathogenic Escherichia coli secreted protein F (EspF) and is redistributed after infection. Cell Microbiol 6: 987-997.
21. Kenny B, Jepson M, (2000) Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria. Cell Microbiol 2: 579-590.
22. McNamara BP, Koutsouris A, O'Connell CB, Nougayrede JP, Donnenberg MS, et al. (2001) Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J Clin Invest 107: 621-629.
23. Dean P, Kenny B, (2004) Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol Microbiol 54: 665-675.
24. Dean P, Maresca M, Schuller S, Phillips AD, Kenny B, (2006) Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins. Proc Natl Acad Sci U S A 103: 1876-1881.
25. Quitard S, Dean P, Maresca M, Kenny B, (2006) The enteropathogenic Escherichia coli EspF effector molecule inhibits PI-3 kinase-mediated uptake independently of mitochondrial targeting. Cell Microbiol 8: 972-981.
26. Holmes A, Muhlen S, Roe AJ, Dean P, (2010) The EspF effector, a bacterial pathogen's Swiss army knife. Infect Immun 78: 4445-4453.
27. Kenny B, Valdivia R, (2009) Host-microbe interactions: bacteria. Curr Opin Microbiol 12: 1-3.
28. Allan LA, Clarke PR, (2009) Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation. FEBS J 276: 6063-6073.
29. Zou H, Yang R, Hao J, Wang J, Sun C, et al. (2003) Regulation of the Apaf-1/caspase-9 apoptosome by caspase-3 and XIAP. J Biol Chem 278: 8091-8098.
30. Fujii J, Kita T, Yoshida S, Takeda T, Kobayashi H, et al. (1994) Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect Immun 62: 3447-3453.
31. Yuan LX, Sun Y, Yang YJ, (2008) The research on mechanism of programmed cell death. Journal of Shanxi Agricultural Sciences 36: 15-17.
32. Ni XP, Xun JR, Zha J, Jiang HQ, Yu GQ, et al. (2002) Studies of persistence of experimental Escherichia coli O157:H7 carrier in Mouse. Chinese Journal of Zoonoses 18: 74-76.
33. Wadolkowski EA, Burris JA, O'Brien AD, (1990) Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 58: 2438-2445.
34. Vallance BA, Deng W, Jacobson K, Finlay BB, (2003) Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect Immun 71: 3443-3453.
35. al-Jumaili I, Burke DA, Scotland SM, al-Mardini H, Record CO, (1992) A method of enhancing verocytotoxin production by Escherichia coli. FEMS Microbiol Lett 72: 121-125.
36. MacLeod DL, Gyles CL, (1989) Effects of culture conditions on yield of Shiga-like toxin-IIv from Escherichia coli. Can J Microbiol 35: 623-629.
37. Kyte J, Doolittle RF, (1982) A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology 157: 105-132.
38. Hopp TP, Woods KR, (1981) Prediction of protein antigenic determinants from amino acid sequences. Proceedings of the National Academy of Sciences of the United States of America 78: 3824-3828.
39. Emini EA, Hughes JV, Perlow DS, Boger J, (1985) Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. Journal of Virology 55: 836-839.
40. Jameson BA, Wolf H, (1988) The antigenic index: a novel algorithm for predicting antigenic determinants. Computer Applications in the Biosciences 4: 181-186.
41. Weidmann E, Brieger J, Jahn B, Hoelzer D, Bergmann L, et al. (1995) Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia. Ann Hematol 70: 153-158.